Anoro Ellipta 62.5 ug/1 62.5 ug/1 POWDER

Anoro Ellipta 62.5 ug/1

Active Ingredient:
umeclidinium bromide and vilanterol trifenatate
Form:
POWDER
Brand:
Anoro Ellipta
Origin:
USA

Buy Anoro Ellipta 62.5 ug/1 umeclidinium bromide and vilanterol trifenatate

Anoro Ellipta 62.5 ug/1 is a combination inhaler containing umeclidinium bromide and vilanterol trifenatate. It is designed for respiratory use and is commonly used for managing chronic obstructive pulmonary disease (COPD). This powder inhaler offers a convenient way to administer medication directly to the lungs.

Strength

62.5 ug/1

Pack Size

1 TRAY in 1 CARTON (0173-0869-06) / 1 INHALER in 1 TRAY / 7 POWDER in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Anoro Ellipta 62.5 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It combines two active ingredients, umeclidinium bromide and vilanterol trifenatate, to help improve breathing and reduce symptoms associated with COPD. This inhaler is designed for long-term use and is not intended for immediate relief of sudden breathing problems.

Side Effects

  • Common effects of using Anoro Ellipta 62.5 ug/1 may include improved lung function and reduced shortness of breath. Users often experience better control over their respiratory symptoms, allowing for more comfortable daily activities. Some individuals may also notice a decrease in the frequency of COPD exacerbations.

Precautions & Warnings

  • Anoro Ellipta 62.5 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to ensure safe and effective use. Patients with certain medical conditions, such as heart disease or severe asthma, should consult their healthcare provider before using this inhaler.

Avoid Interactions

  • Anoro Ellipta 62.5 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional.

References

Frequently Asked Questions

Anoro Ellipta 62.5 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD).

Anoro Ellipta 62.5 ug/1 is administered via inhalation. Follow the instructions provided by your healthcare professional for proper use.

Common effects may include improved lung function and reduced shortness of breath, helping to manage COPD symptoms.

Yes, it is important to use Anoro Ellipta 62.5 ug/1 as directed by a healthcare professional and to inform them of any other medications you are taking.

Yes, Anoro Ellipta 62.5 ug/1 may interact with other medications, including beta-blockers and certain antidepressants. Consult your healthcare provider for more information.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT